Adicet Bio Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Adicet Bio stock has a consensus rating of "Strong Buy" and an average price target of $34.83. The average 1-year stock price forecast is 330.00% higher than the current stock price, while the lowest is $18 (+122.22%) and the highest is $100 (+1,134.57%).

Price Target: $34.83 (+330.00%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$18	$34.83	$22.5	$100
Change	+122.22%	+330.00%	+177.78%	+1134.6%

* Price targets were last updated on May 14, 2026.

Analyst Ratings

The average analyst rating for Adicet Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	7	6	6	6
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Boris Peaker JonesTrading	JonesTrading	Buy Maintains $20	Buy	Maintains	$20	+146.91%	May 14, 2026
Unknown Analyst Wedbush No rating	Wedbush	Buy Reiterates $25	Buy	Reiterates	$25	+208.64%	May 14, 2026
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $18	Buy	Maintains	$18	+122.22%	May 14, 2026
Anthea Li Jefferies	Jefferies	Buy Initiates $8 → $19	Buy	Initiates	$8 → $19	+134.57%	May 4, 2026
Robert Burns H.C. Wainwright	H.C. Wainwright	Buy Reiterates $50 → $27	Buy	Reiterates	$50 → $27	+233.33%	Mar 23, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

34.23M

EPS This Year

-8.87

from -16.95

EPS Next Year

-4.19

from -8.87

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	9.73M	24.99M	-	-	-	-
Gross Profit	9.73M	24.99M	-	-	-	-
Gross Margin	100.00%	100.00%	-	-	-	90.00%
Operating Income	-60.24M	-72.55M	-132.58M	-127.62M	-122.11M	-105.99M
Net Income	-62.00M	-69.79M	-142.66M	-117.12M	-116.80M	-102.64M
EPS	-	-	-	-	-16.95	-8.87
Free Cash Flow	-42.27M	-38.41M	-61.28M	-53.22M	-53.87M	-68.70M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-5.28
Avg	-8.87
Low	-12.19

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-